All news articles for April 28, 2023

© Eva-Katalin / Getty Images

Osaka gets FDA GRAS no objection for D-BHB ingredient

By Stephen Daniells

The US Food and Drug Administration has issued a letter of no objection to Osaka Gas Chemicals regarding the GRAS status of the company’s D-beta-hydroxybutyric acid (D-BHB) ingredient.

FDA: SARMs not worth the health risk ‘for a few extra likes’

FDA: SARMs not worth the health risk ‘for a few extra likes’

By Asia Sherman

The U.S. Food and Drug Administration (FDA) issued an advisory this week warning of adverse event reports related to selective androgen receptor modulators (SARMs). In the letter, the agency also takes issue with online vendors and social media influencers...

Follow us

Products

View more

Webinars